Literature DB >> 8217189

Interleukin-8-induced transcellular neutrophil migration is facilitated by endothelial and pulmonary epithelial cells.

S J Smart1, T B Casale.   

Abstract

Interleukin-8 (IL-8) is an 8,000 D protein produced by many cells and has potent neutrophil chemoattractant and activating properties. Indeed, there is substantial data supporting a role for IL-8 in neutrophilic lung inflammatory responses. In vivo, neutrophils must adhere to and then migrate across endothelial and epithelial cell barriers in order to reach inflammatory foci. Therefore, we examined IL-8-induced neutrophil migration through naked filters and through human umbilical vein endothelial (HUVE) cells and human pulmonary type II-like epithelial cells (A549) cultured on these filters. IL-8 induced both dose- and time-dependent migration of neutrophils across all three barriers. At IL-8 concentrations greater than 10(-8) M, neutrophil migration across both endothelial and epithelial cell barriers was significantly greater than that observed across naked filters. In addition, time-course experiments indicated that neutrophil migration continued to occur for up to 3 h across both cellular barriers while neutrophil migration across naked filters plateaued by approximately 60 to 90 min. Migration of neutrophils through all barriers was completely inhibited by anti-IL-8 neutralizing antibody. The increased migration observed through both cellular barriers was not due to either changes in chemotactic gradients or the production of other soluble chemotactic factors by IL-8-stimulated HUVE and A549 cells versus naked filters. Furthermore, pretreatment of monolayers with actinomycin-D had no effect on the degree of transcellular migration. Thus, the facilitation of neutrophil migration through HUVE and A549 monolayers is not dependent upon new protein synthesis.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8217189     DOI: 10.1165/ajrcmb/9.5.489

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  8 in total

1.  Cytokines induce selective granulocyte chemotactic responses.

Authors:  D B Bittleman; R A Erger; T B Casale
Journal:  Inflamm Res       Date:  1996-02       Impact factor: 4.575

2.  Interleukin-8 gene expression in Staphylococcus aureus-infected endothelial cells.

Authors:  L Yao; F D Lowy; J W Berman
Journal:  Infect Immun       Date:  1996-08       Impact factor: 3.441

3.  Release of CXC-chemokines by human lung microvascular endothelial cells (LMVEC) compared with macrovascular umbilical vein endothelial cells.

Authors:  G C Beck; B A Yard; A J Breedijk; K Van Ackern; F J Van Der Woude
Journal:  Clin Exp Immunol       Date:  1999-11       Impact factor: 4.330

4.  Image-based analysis of primary human neutrophil chemotaxis in an automated direct-viewing assay.

Authors:  Ivar Meyvantsson; Elizabeth Vu; Casey Lamers; Daniella Echeverria; Tracy Worzella; Victoria Echeverria; Allyson Skoien; Steven Hayes
Journal:  J Immunol Methods       Date:  2011-01-05       Impact factor: 2.303

5.  Gene Expression of Pregnancy Neutrophils Differs for Protease versus Lipopolysaccharide Stimulation.

Authors:  Scott W Walsh; Marwah Al Dulaimi; Jerome F Strauss
Journal:  Int J Mol Sci       Date:  2022-04-28       Impact factor: 6.208

6.  Plasma from preeclamptic women stimulates transendothelial migration of neutrophils.

Authors:  Scott W Walsh
Journal:  Reprod Sci       Date:  2008-12-15       Impact factor: 3.060

7.  The tyrosine kinase Pyk2 mediates lipopolysaccharide-induced IL-8 expression in human endothelial cells.

Authors:  Appakkudal R Anand; Magali Cucchiarini; Ernest F Terwilliger; Ramesh K Ganju
Journal:  J Immunol       Date:  2008-04-15       Impact factor: 5.422

8.  Pre-Activated Granulocytes from an Autoimmune Uveitis Model Show Divergent Pathway Activation Profiles upon IL8 Stimulation In Vitro.

Authors:  Anne L C Hoffmann; Stefanie M Hauck; Cornelia A Deeg; Roxane L Degroote
Journal:  Int J Mol Sci       Date:  2022-08-23       Impact factor: 6.208

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.